Skip to main content

Displaying results 1 - 3 of 3
  • Content Type: Abstract

    Adverse drug events (ADEs) are a significant source of morbidity and mortality. The majority of post-marketing surveillance for ADEs is passive. Information regarding ADEs is reported to the medical community in peer-reviewed journals. However, in… read more
    … journals, our intuition is that letters to the editor may provide the earliest reports of ADEs. They often report … formal investigations and reports. Although these letters may contain useful and timely information, the challenge is … ehtj11115 ehtj11120 ehtj11024 ehtj11060 ehtj11110 26-50 ehtj11034 ehtj11198 ehtj11174 ehtj11048 ehtj11154 …
  • Content Type: Abstract

    Investigators have used the volume of internet search queries to model disease incidence, especially influenza and general consumer behavior [1]. Our group has used search volume to model interest in FDA safety alerts and adverse drug event… read more
    … and adverse drug event incidence. Thus, search volume may help provide near real time sur- veillance of drug use … and adverse drug event incidence. Thus, search volume may help provide near real time sur- veillance of drug use …
  • Content Type: Abstract

    Adverse drug events (ADEs) are a major cause of morbidity and mortality. However, post-marketing surveillance systems are passive and reporting is generally not mandated. Thus, many ADEs go unreported, and it is difficult to estimate and/or… read more
    … approval. Finally, the severity and frequency of ADEs may vary within a particular drug class, and search volume may provide additional information for guiding clinicians to … ehtj11115 ehtj11120 ehtj11024 ehtj11060 ehtj11110 26-50 ehtj11034 ehtj11198 ehtj11174 ehtj11048 ehtj11154 …